<p>PRNT and ELISA GMTs, seroconversion rates and GMT group ratios 2 weeks after the second vaccination (PPS, n = 2549).</p
<p>Seroconversion rate between March and October 2010 in 705 vaccinated participants.</p
<p>Abbreviations: HAI, hemagglutination inhibition test; IgG*, pandemic H1N1-specific IgG, immunoglo...
<p>(A, B) SPR for Enzygnost, Immunozym and RFFIT for individuals that have received 3 (A) or 4 (B) v...
*<p>HAI titre >1∶32.</p>**<p>HAI titer ≤1∶8 before and at least 1∶32 after vaccination or baseline H...
<p>Seroprotection, seroconversion and GMT fold increase 28 days post immunization for subjects in th...
<p>N = number of subjects in the specified group.</p><p>GMT for ELISA and PRNT at all post-baseline ...
Frequency of antibody responses as determined by ELISA four weeks after the final vaccination.</p
<p>Two subjects, P005 and P039, who did not deliver at the study site were not included in this anal...
<p>N: number of total participants included in the analyses. Data are GMT (95% CI) or GMFI (95% CI)....
Distribution of VITROS S-IgG and cPass sVNT values in participants after second vaccination.</p
<p>A*, Aluminium hydroxide; P*, poly(I:C); C*, CpG; I*, IFA.</p><p>Vaccination groups and seroconver...
<p>Data presented as mean ± standard deviation or number (percentage).</p><p>a: Mc'Nemar exact test ...
<p>P: Pregnant.</p><p>NP: Non-pregnant.</p><p>GMT: Geometric mean titer.</p><p>GMR: Geometric mean r...
<p>GP consultation rate ratios and 95% CIs (per three months) by vaccination status, two years befor...
<p>SPR and GMT in relation to number of vaccine doses (0–5), or previous TBE disease. The “0(ab)” gr...
<p>Seroconversion rate between March and October 2010 in 705 vaccinated participants.</p
<p>Abbreviations: HAI, hemagglutination inhibition test; IgG*, pandemic H1N1-specific IgG, immunoglo...
<p>(A, B) SPR for Enzygnost, Immunozym and RFFIT for individuals that have received 3 (A) or 4 (B) v...
*<p>HAI titre >1∶32.</p>**<p>HAI titer ≤1∶8 before and at least 1∶32 after vaccination or baseline H...
<p>Seroprotection, seroconversion and GMT fold increase 28 days post immunization for subjects in th...
<p>N = number of subjects in the specified group.</p><p>GMT for ELISA and PRNT at all post-baseline ...
Frequency of antibody responses as determined by ELISA four weeks after the final vaccination.</p
<p>Two subjects, P005 and P039, who did not deliver at the study site were not included in this anal...
<p>N: number of total participants included in the analyses. Data are GMT (95% CI) or GMFI (95% CI)....
Distribution of VITROS S-IgG and cPass sVNT values in participants after second vaccination.</p
<p>A*, Aluminium hydroxide; P*, poly(I:C); C*, CpG; I*, IFA.</p><p>Vaccination groups and seroconver...
<p>Data presented as mean ± standard deviation or number (percentage).</p><p>a: Mc'Nemar exact test ...
<p>P: Pregnant.</p><p>NP: Non-pregnant.</p><p>GMT: Geometric mean titer.</p><p>GMR: Geometric mean r...
<p>GP consultation rate ratios and 95% CIs (per three months) by vaccination status, two years befor...
<p>SPR and GMT in relation to number of vaccine doses (0–5), or previous TBE disease. The “0(ab)” gr...
<p>Seroconversion rate between March and October 2010 in 705 vaccinated participants.</p
<p>Abbreviations: HAI, hemagglutination inhibition test; IgG*, pandemic H1N1-specific IgG, immunoglo...
<p>(A, B) SPR for Enzygnost, Immunozym and RFFIT for individuals that have received 3 (A) or 4 (B) v...